PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20159824-0	2010	Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.	Abiraterone Acetate	46-65	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	30-35	
20159824-1	2010	PURPOSE: Abiraterone acetate is a prodrug of abiraterone, a selective inhibitor of CYP17, the enzyme catalyst for two essential steps in androgen biosynthesis.	Abiraterone Acetate	9-28	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	83-88